Detailed Notes on cgmp manufacturing
No. 21 CFR 211.113(a) requires acceptable prepared techniques to be recognized and followed during manufacturing to forestall objectionable microorganisms in drug products not needed to be sterile. In addition, the 2nd paragraph of USP Standard Chapter Antimicrobial Usefulness Screening reads: Antimicrobial preservatives shouldn't be made